ginsenoside rh2 has been researched along with Colitis Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, T; Chen, N; Duan, S; Guo, S; He, Z; Li, J; Li, Z; Yi, Q; Zhang, D; Zhu, Z | 1 |
| Chen, X; Liu, S; Lv, X; Xu, T; Zhang, J | 1 |
2 other study(ies) available for ginsenoside rh2 and Colitis Gravis
| Article | Year |
|---|---|
Sijunzi Decoction Targets IL1B and TNF to Reduce Neutrophil Extracellular Traps (NETs) in Ulcerative Colitis: Evidence from Silicon Prediction and Experiment Validation.
Topics: Animals; Colitis, Ulcerative; Cytokines; Drugs, Chinese Herbal; Extracellular Traps; Isoflavones; Mice; Molecular Docking Simulation; Silicon | 2023 |
Ginsenoside Rh2 alleviates ulcerative colitis by regulating the STAT3/miR-214 signaling pathway.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Colitis, Ulcerative; Cytokines; Dextran Sulfate; Disease Models, Animal; Ginsenosides; Humans; Inflammation; Male; Mice, Inbred C57BL; MicroRNAs; Signal Transduction; STAT3 Transcription Factor; Sulfasalazine | 2021 |